Significance of antinuclear antibodies in patients with COVID-19

참고문헌 (9)

1. Ragab D, "The COVID-19 cytokine storm; what we know so far", Front Immunol, 11, pp.1446~ (2020)
2. Liu Y, "COVID-19 and autoimmune diseases", Curr Opin Rheumatol, 33, pp.155~162 (2021)
3. Kouranloo K, "A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19", Rheumatol Int (2023)[DOI]
4. Soo Hyun Park, "Clinical significance of antinuclear antibody positivity in patients with severe coronavirus disease 2019", The Korean Journal of Internal Medicine, 38(3), pp.417~426 (2023), 대한내과학회[DOI]
5. Vahabi M, "Is COVID-19 severity unrelated to antinuclear antibodies?", Transpl Immunol, 78, pp.101791~ (2023)
6. Pascolini S, "COVID-19 and immunological dysregulation : can autoantibodies be useful?", Clin Transl Sci, 14, pp.502~508 (2021)
7. Litwin CM, "ANA testing in the presence of acute and chronic infections", J Immunoassay Immunochem, 37, pp.439~452 (2016)
8. Satoh M, "Prevalence and sociodemographic correlates of antinuclear antibodies in the United States", Arthritis Rheum, 64, pp.2319~2327 (2012)
9. Son K, "Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms", Eur Respir J, 61, pp.2200970~ (2023)

관련 논문AI추천